Pla Frederic 4
4 · Akoya Biosciences, Inc. · Filed Sep 11, 2023
Insider Transaction Report
Form 4
Pla Frederic
Chief Operating Officer
Transactions
- Purchase
Common Stock
2023-09-07$4.60/sh+13,000$59,814→ 13,000 total(indirect: By Trust) - Purchase
Common Stock
2023-09-07$4.60/sh+7,000$32,200→ 20,000 total(indirect: By Trust)
Holdings
- 40,555
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $4.595 to $4.61 for a weighted average sale price of $4.6011. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.